A European evidence-based guideline for the prevention of type 2 diabetes.
- Paulweber, B
- Valensi, P
- Lindström, J
- Lalic, NM
- Greaves, CJ
- McKee, M
- Kissimova-Skarbek, K
- Liatis, S
- Cosson, E
- Szendroedi, J
- Sheppard, KE
- Charlesworth, K
- Felton, A-M
- Hall, M
- Rissanen, A
- Tuomilehto, J
- Schwarz, PE
- Roden, M
- Paulweber, M
- Stadlmayr, A
- Kedenko, L
- Katsilambros, N
- Makrilakis, K
- Kamenov, Z
- Evans, P
- Gilis-Januszewska, A
- Lalic, K
- Jotic, A
- Djordevic, P
- Dimitrijevic-Sreckovic, V
- Hühmer, U
- Kulzer, B
- Puhl, S
- Lee-Barkey, YH
- AlKerwi, A
- Abraham, C
- Hardeman, W
- Acosta, T
- Adler, M
- AlKerwi, A
- Barengo, N
- Barengo, R
- Boavida, JM
- Charlesworth, K
- Christov, V
- Claussen, B
- Cos, X
- Cosson, E
- Deceukelier, S
- Dimitrijevic-Sreckovic, V
- Djordjevic, P
- Evans, P
- Felton, A-M
- Fischer, M
- Gabriel-Sanchez, R
- Gilis-Januszewska, A
- Goldfracht, M
- Gomez, JL
- Greaves, CJ
- Hall, M
- Handke, U
- Hauner, H
- Herbst, J
- Hermanns, N
- Herrebrugh, L
- Huber, C
- Hühmer, U
- Huttunen, J
- Jotic, A
- Kamenov, Z
- Karadeniz, S
- Katsilambros, N
- Khalangot, M
- Kissimova-Skarbek, K
- Köhler, D
- Kopp, V
- Kronsbein, P
- Kulzer, B
- Kyne-Grzebalski, D
- Lalic, K
- Lalic, N
- Landgraf, R
- Lee-Barkey, YH
- Liatis, S
- Lindström, J
- Makrilakis, K
- McIntosh, C
- McKee, M
- Mesquita, AC
- Misina, D
- Muylle, F
- Neumann, A
- Paiva, AC
- Pajunen, P
- Paulweber, B
- Peltonen, M
- Perrenoud, L
- Pfeiffer, A
- Pölönen, A
- Puhl, S
- Raposo, F
- Reinehr, T
- Rissanen, A
- Robinson, C
- Roden, M
- Rothe, U
- Saaristo, T
- Scholl, J
- Schwarz, PE
- Sheppard, KE
- Spiers, S
- Stemper, T
- Stratmann, B
- Szendroedi, J
- Szybinski, Z
- Tankova, T
- Telle-Hjellset, V
- Terry, G
- Tolks, D
- Toti, F
- Tuomilehto, J
- Undeutsch, A
- Valadas, C
- Valensi, P
- Velickiene, D
- Vermunt, P
- Weiss, R
- Wens, J
- Yilmaz, T
DOIAbstract
BACKGROUND: The prevalence and socioeconomic burden of type 2 diabetes (T2DM) and associated co-morbidities are rising worldwide. AIMS: This guideline provides evidence-based recommendations for preventing T2DM. METHODS: A European multidisciplinary consortium systematically reviewed the evidence on the effectiveness of screening and interventions for T2DM prevention using SIGN criteria. RESULTS: Obesity and sedentary lifestyle are the main modifiable risk factors. Age and ethnicity are non-modifiable risk factors. Case-finding should follow a step-wise procedure using risk questionnaires and oral glucose tolerance testing. Persons with impaired glucose tolerance and/or fasting glucose are at high-risk and should be prioritized for intensiv...
Add to ORKG